title: Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells.
abstract: Thiazolidinediones (TZD), a class of anti-diabetic drugs, determine bone loss and increase fractures particularly in post-menopausal women, thus suggesting a protective role of sex steroids. We have previously demonstrated that the TZD rosiglitazone (RGZ) negatively affects bone mass by inhibiting osteoblastogenesis, yet inducing adipogenesis, in bone marrow-derived human mesenchymal stem cells (hMSC). The aim of this study was to determine whether estrogens and androgens are able to revert the effects of RGZ on bone. hMSC express estrogen receptor α and β and the androgen receptor. We found that 17β-estradiol (10 nM), the phytoestrogen genistein (10 nM), testosterone (10 nM) and the non-aromatizable androgens dihydrotestosterone (10 nM) and methyltrienolone (10 nM) effectively counteracted the adipogenic effect of RGZ (1 μM) in hMSC induced to differentiate into adipocytes, as determined by evaluating the expression of the adipogenic marker peroxisome proliferator-activated receptor γ and the percentage of fat cells. Furthermore, when hMSC were induced to differentiate into osteoblasts, all the above-mentioned molecules and also quercetin, another phytoestrogen, significantly reverted the inhibitory effect of RGZ on the expression of the osteogenic marker osteocalcin and decreased the number of fat cells observed after RGZ exposure. Our study represents, to our knowledge, the first demonstration in hMSC that androgens, independently of their aromatization, and estrogens are able to counteract the negative effects of RGZ on bone. Our data, yet preliminary, suggest the possibility to try to prevent the negative effects of TZD on bone, using steroid receptor modulators, such as plant-derived phytoestrogens, which lack evident adverse effects.
authors: Endocrine Unit, Department of Clinical Physiopathology, Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders, University of Florence, Viale Pieraccini 6, Florence, Italy.
authors: S
authors: S
authors: Benvenuti
authors: I
authors: I
authors: Cellai
authors: P
authors: P
authors: Luciani
authors: C
authors: C
authors: Deledda
authors: R
authors: R
authors: Saccardi
authors: B
authors: B
authors: Mazzanti
authors: S
authors: S
authors: Dal Pozzo
authors: M
authors: M
authors: Serio
authors: A
authors: A
authors: Peri
references: J Nutr Biochem. 2009 Feb;20(2):140-8
references: 18547799
references: Ann Biomed Eng. 2008 Dec;36(12):1978-91
references: 18855142
references: Exp Cell Res. 2006 Aug 1;312(13):2592-604
references: 16762343
references: Clin Endocrinol (Oxf). 2010 Sep;73(3):305-12
references: 20148906
references: Physiol Rev. 2001 Jan;81(1):419-447
references: 11152762
references: J Endocrinol Invest. 2007 Oct;30(9):RC26-30
references: 17993761
references: Cytotherapy. 2006;8(4):315-7
references: 16923606
references: J Agric Food Chem. 2010 May 12;58(9):5821-7
references: 20397699
references: Nat Rev Endocrinol. 2009 Aug;5(8):437-43
references: 19528961
references: J Neuroendocrinol. 2005 Jan;17(1):57-64
references: 15720476
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9416-21
references: 12872002
references: Calcif Tissue Int. 2010 May;86(5):343-9
references: 20354684
references: J Clin Endocrinol Metab. 2006 Sep;91(9):3349-54
references: 16608888
references: N Engl J Med. 2006 Dec 7;355(23):2427-43
references: 17145742
references: J Endocrinol Invest. 2010;33(7 Suppl):9-12
references: 20938219
references: Mol Cell Endocrinol. 2008 Dec 16;296(1-2):32-40
references: 18801408
references: J Clin Endocrinol Metab. 2010 Feb;95(2):592-600
references: 20061432
references: Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):250-4
references: 18438173
references: Mol Nutr Food Res. 2009 Sep;53(9):1084-97
references: 19653225
references: J Biol Chem. 2003 Jan 10;278(2):962-7
references: 12421816
references: Endocr Rev. 2004 Jun;25(3):389-425
references: 15180950
references: Arch Intern Med. 2009 Aug 10;169(15):1395-402
references: 19667303
references: Osteoporos Int. 2008 Nov;19(11):1517-25
references: 18392663
references: Endocrinology. 2005 Mar;146(3):1226-35
references: 15591153
references: Science. 1999 Apr 2;284(5411):143-7
references: 10102814
references: J Clin Endocrinol Metab. 2010 Oct;95(10):4560-5
references: 20631021
references: Endocrinology. 2004 Feb;145(2):848-59
references: 14605006
references: Expert Rev Neurother. 2007 Nov;7(11):1549-64
references: 17997703
references: Menopause. 2008 Jul-Aug;15(4 Pt 1):748-57
references: 18277912
references: Am J Med. 2009 Oct;122(10):939-46.e9
references: 19786161
references: Bone. 2009 Oct;45(4):784-8
references: 19527806
references: Endocrinology. 2003 Nov;144(11):5081-8
references: 12960001
references: Curr Osteoporos Rep. 2010 Dec;8(4):178-84
references: 20809203
references: Proc Nutr Soc. 2008 May;67(2):184-95
references: 18412992
references: J Clin Endocrinol Metab. 2007 Apr;92(4):1305-10
references: 17264176
references: J Endocrinol. 2004 Oct;183(1):203-16
references: 15525588
references: Mol Cell Endocrinol. 2009 Oct 30;310(1-2):3-10
references: 18789372
references: PLoS Med. 2009 Sep;6(9):e1000154
references: 19787025